Selegiline HCL Tablets USP 5mg, 60- count bottles, Rx only, Manufactured by: Stason Pharmaceuticals, Inc. Irvine, CA 92618 Distributed by: Libertas Pharma, Inc. Montgomery, AL 36117. NDC 51862-146-06
Published September 14, 2016 · Recall initiated: August 23, 2016
Summary
FDA records drug Class III recall D-1479-2016, published September 14, 2016 and initiated August 23, 2016. Recalling firm: Stason Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 17,013 units; Lot: Lot #: 14F030, 14F031, 14F032, Exp. June 2017; 15G022, Exp. July 2018. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Stason Pharmaceuticals is recalling Selegiline HCl tablets, USP 5mg 60 count bottle due to an out of specification result for dissolution of stability samples.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Stason Pharmaceuticals, Inc.
- Distributor
- North Carolina
- Lot
- Lot #: 14F030, 14F031, 14F032, Exp. June 2017; 15G022, Exp. July 2018
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottleMarch 13, 2024
- FDADextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and AmphetamineSeptember 14, 2016
- FDADextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and AmphetamineSeptember 14, 2016
- FDASPECULAR MICROSCOPE CEM-530; Software version 1.08 and 1.09. Opthalmic: The NIDEK Specular Microscope CEM-530September 7, 2016
- FDADouble Pump RF Patient Cassette; Product Number: 72204055. Intended to provide fluid distension and irrigationSeptember 7, 2016
- FDAADVIA Chemistry XPT, SMN 10723034, IVD. --- This issue affects only the ADVIA Chemistry Hemoglobin A1c_3September 7, 2016
Questions about this recall
Was Selegiline HCL Tablets USP 5mg, 60- count bottles, Rx only, Manufactured by: Stason Pharmaceuticals, Inc. Irvine, CA 92618 Distributed by: Libertas Pharma, Inc. Montgomery, AL 36117. NDC 51862-146-06 recalled?
Yes. FDA published recall D-1479-2016 on September 14, 2016. Reported hazard: Stason Pharmaceuticals is recalling Selegiline HCl tablets, USP 5mg 60 count bottle due to an out of specification result for dissolution of stability samples.
What should I do if I have this product?
Voluntary: Firm initiated · Letter